Strip out the megadeals and the record M&A year is down 4%.

Is 2026 a record year or a shrinking one?

Both, and the difference is size. Global deal value is on track for roughly $4 trillion in 2026, up 13% on 2025, across about 42,000 transactions, down 13%. Value rose. Count fell. That inversion is the year (PwC, Global M&A industry trends: 2026 mid-year outlook, data through 31 May 2026).

The inversion has one cause. Transactions above $5bn now account for 48% of global deal value, against 39% in 2025 and 26% in 2024, and megadeal value is on track to rise about 40% year on year. Remove those transactions and global deal value is down 4%.

The United States shows it most cleanly. There were 4,653 deals worth $1.2 trillion in the first five months of 2026, against 4,851 deals worth $603 billion in the same period a year earlier: nearly double the dollars across fewer transactions (PwC, US Deals 2026 midyear outlook, 17 June 2026, covering 1 January to 31 May 2026). The Americas produced 61% of global deal value on 28% of global deal volume.

So the honest benchmark for a business below megadeal scale is not plus 13%. It is minus 4%. An owner reading about a record autumn is reading about roughly thirty-nine American transactions, not about the market that will price their company.

Is the middle market moving, or just the headlines?

It is moving, by count, and unevenly by size band. Closed middle-market deal volume rose 12.5% quarter on quarter and 10.7% year on year in Q1 2026, on $45 billion of disclosed transaction value, up 26.8% (Capstone Partners, Capital Markets Update, 4 June 2026).

Supply is at a record at the small end. A total of 3,523 businesses came to market through Axial in Q2 2026, up 4.79% year on year and the highest quarterly total the platform has recorded, across a $2.5m to $250m enterprise-value population (Axial, The SMB M&A Pipeline: Q2 2026, 21 July 2026). Six of seven sectors rose.

Practitioners expect more of it. In the ACG and GF Data Q3 2026 Market Pulse Survey, fielded at the start of Q3 2026 and published on 15 July 2026, 63% of respondents expected M&A activity to increase over the following six months, a slight improvement on the Q2 reading, and 49% expected the financing environment to stay favourable.

The band that is not participating is the one in the middle. Capstone describes the core middle market, $100m to $250m of enterprise value, as comparatively more constrained, sitting between small self-funded bolt-ons and large institutional assets. A business in that band is too large for the self-funded and independent-sponsor universe and too small to be a must-own. It is worth saying that to an owner directly rather than letting a headline growth rate imply otherwise.

Who is the buyer into 2027?

The corporate strategic, and a fundless buyer universe that has roughly doubled. The committed-fund sponsor is a thinner bid than it was eighteen months ago, and the second sponsor bid has largely gone.

US private equity deal value fell to $177.3 billion in Q2 2026, down 37.5% on the quarter and 23.9% on the year, the lowest reading since Q4 2023, while sponsor deal count rose 11.5% year on year to 2,384 (PitchBook Q2 2026 US PE Breakdown, published 6 July 2026). Sponsors did not stop buying. They stopped buying big. A separate leveraged-loan-linked series reports the same quarter as $137 billion, so the level depends on which dataset is quoted; the direction does not.

Exits are where the pressure shows. US private equity exits fell 46% on the quarter to $102.6 billion, with sponsor-to-sponsor sales down 57% to $24.5 billion on a count down 38% to 94, the lowest quarterly mark in at least a decade (PitchBook, Q2 2026 US PE Breakdown, 6 July 2026). A process built on the assumption that another sponsor will underwrite a competing bid is a process built on a channel that is currently closed.

Two things have moved in to fill it. There are now roughly 1,400 active independent sponsors, about double the 2019 count (Bloomberg, 28 July 2026, citing McGuireWoods). And corporate separations are running 145% above the 2021 to 2025 average year to date (Goldman Sachs, 2H 2026 Global M&A Outlook, 22 July 2026, survey fielded 15 June to 6 July 2026). Carve-outs are middle-market-sized assets sold by motivated large sellers, which makes them both supply and demand.

Behind all of it sits the inventory. Around 32,000 companies sit unexited in global private equity portfolios (EY Global Private Equity Exit Readiness Study 2026, 28 July 2026), carrying roughly $3.8 trillion of value as at year-end 2025 (Bain & Company). At 31 March 2026, 34% of those holdings had been held more than five years (PwC, citing PitchBook data as at 31 March 2026). At the current pace, clearing the US portion would take a near-record nine years (PwC, US Deals 2026 midyear outlook, 17 June 2026).

What clears, and at what price?

The median holds. The dispersion widens. Most ACG and GF Data respondents expect valuations to stay steady over the six months from the start of Q3 2026, and they rank mismatched buyer and seller price expectations as the second-largest risk to middle-market M&A. One respondent put the split plainly: multiples for A-grade targets are insanely high, and lower-grade companies are not getting bids (ACG and GF Data Q3 2026 Market Pulse Survey, 15 July 2026).

The latest published middle-market print is Q1 2026: 7.3x total enterprise value to EBITDA across all deals, up from 6.9x in Q4 2025, with platform acquisitions at 7.6x against add-ons at 6.5x, the widest spread in the series, and size bands running roughly 7x at $10m to $50m of enterprise value against roughly 9x to 11x at $100m to $500m (Mercer Capital, Middle Market Transaction Update, Summer 2026, reporting GF Data for Q1 2026). Transactions above $250m averaged 12.2x in the same quarter on a different dataset (Capstone Partners, 4 June 2026). Scale is worth two to four turns. Platform status is worth about one.

Where price will not close the gap, structure does. Some 24% of private-target deals outside life sciences now carry an earnout, up from 19% in 2014, and across deals that have one, closer to one in five earnout dollars is actually paid (SRS Acquiom, M&A Earnout and Milestone Trends, published 7 July 2026, on a full-year 2025 deal population). At the bottom of the market the share is higher: 35% of deals with closing payments of $25m or less include an earnout, and 29% across all deals at $50m or less, a population in which private equity buyers were involved in only 11% of transactions (SRS Acquiom, 2026 M&A Deal Terms Special Report: Lower Middle-Market Deals, 5 June 2026, drawn from more than 4,400 private-target transactions closed through 2025).

Treat contingent consideration as roughly a twenty-cent dollar when comparing two offers. And note that the signed number is rarely the wired number: 93% of deals carry a purchase price adjustment mechanism, and 89% of those with one recorded an actual adjustment (SRS Acquiom, 19 May 2026, on a pooled 2020 to 2025 transaction population).

What does waiting cost now?

For about eighteen months, waiting was a free option, because the next move in rates was expected to be down. It is not free now. The Federal Reserve held at 3.50% to 3.75% in mid-June 2026 and removed its easing bias, then held again on 29 July 2026 by a vote of nine to three, with all three dissents in favour of raising by 25 basis points (Federal Reserve, FOMC statement, 29 July 2026).

Middle-market dealmakers have already repriced the behaviour. ACG and GF Data respondents cited chatter of an impending rate rise as a key influence on the second half, with one noting there could be pressure to get deals done now before rates go up (15 July 2026). Any 2027 model that assumes a financing tailwind is unsupported by the published record.

The second cost of waiting is time. Among 150 senior US investment-bank executives, 73% expect the due diligence process to become more complex over the next twelve to twenty-four months, a window running into 2028. One in five report that timelines have already extended over the past two years, and of those, 57% put the extension at one to three additional months. The incremental time is not financial: 51% now call technology diligence the single most burdensome element of the review, and 84% anticipate increased cybersecurity scrutiny (SRS Acquiom and Mergermarket, M&A Due Diligence Study 2026, published 23 February 2026, fielded Q4 2025).

So plan launch-to-close on the historical baseline plus one to three months, and put the added workstreams in front of the process rather than inside it. The concrete preparation standard for this market is at least 36 months of clean, normalized monthly financials, a quality-of-earnings report commissioned early, and diligence readiness extended to technology and cybersecurity (Capstone Partners, 4 June 2026). Companies that closed successfully were the ones whose financial packages minimized re-trading risk.

None of that is a forecast. It is the part of a 2027 outcome that is decided before a buyer is in the room.